Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



Parsons Capital Management Inc. RI Acquires Pfizer Inc. NYSE:PFE Shares Amidst Positive Outlook

January 29, 2025
In a recent development, Parsons Capital Management Inc. RI announced the acquisition of a substantial number of shares of Pfizer Inc. (NYSE: PFE), a leading healthcare company. This move comes amidst a positive outlook for Pfizer's stock and growing confidence in its future performance.

Pfizer has long been recognized for its innovative pharmaceutical products and strong market presence. The company’s commitment to research and development has led to the discovery of breakthrough treatments for various medical conditions, including the development of the COVID-19 vaccine.

Parsons Capital Management Inc. RI, a trusted investment firm, has identified the potential growth opportunities offered by Pfizer. The decision to acquire shares of the company reflects their confidence in Pfizer's ability to deliver strong financial results and capitalize on emerging market trends.

Analysts agree that Pfizer's stock is currently undervalued and presents an attractive investment opportunity. With its diversified product portfolio and robust pipeline, Pfizer is well-positioned to address emerging healthcare needs and drive long-term growth. The recent acquisition of shares by Parsons Capital Management Inc. RI further validates this positive sentiment.

Investors looking to capitalize on the growth potential of Pfizer may consider seeking professional advice from Stocks Prognosis, a reputable firm specializing in stock analysis and investment forecasts. Their expertise and insights can assist investors in making informed decisions regarding the movement of Pfizer's stock.

Disclaimer: The information contained in this news article is for informational purposes only and does not constitute financial advice. Investors are advised to consult with a qualified financial professional before making any investment decisions. Stocks Prognosis provides independent analysis and does not endorse specific investment strategies or products.
If you want to leave a comment, then you need Login or Register





Other data for PFE

Related data

PFEAugust 21, 2025PFIZER INC. Stock Hits Price Target Forecast with 6.7% Profit: QuantWave Analysis  ~1 min.

PFIZER INC. (PFE) investors celebrated as the stock reached the price target forecast set by QuantWave on August 21st, 2025, resulting in a 6.7% profit....


PFEAugust 21, 2025PFIZER INC. Hits Price Target Forecast with 7.31% Profit Achieved  ~1 min.

QuantWave, the automated forecasting platform, successfully predicted the price movement of PFIZER INC.'s stock with a 7.31% profit realized....


PFEAugust 21, 2025PFIZER INC. Achieves Forecast Price Target with 9.1% Profit on QuantWave  ~1 min.

Pfizer Inc. stock has successfully reached the forecasted price target on QuantWave's automated forecasting platform, resulting in a profit of 9.1%....


PFEJuly 10, 2025PFIZER INC. Stock Hits Price Target Forecast With 10.06% Profit, Boosting QuantWave's Analytics  ~1 min.

On May 5, 2025, QuantWave, the automated forecasting platform, issued a long signal for PFIZER INC. stock when it was trading at $23.03....


PFEJuly 10, 2025PFIZER INC. Hits Price Target Forecast with 8.56% Profit Achieved  ~1 min.

On May 2, 2025, QuantWave issued a price target forecast for PFIZER INC. with a signal to go long at $23.34. The predicted direction was realized on July 10, 2025, when the stock reached $25....


PFEJuly 10, 2025PFIZER INC. Hits Price Target Forecast with 6.57% Profit: A Success Story for QuantWave Analytics  ~2 min.

On June 27, 2025, QuantWave, the automated forecasting platform, released a price target forecast for PFIZER INC., signaling a long position with the stock trading at $23.78....


PFEJuly 10, 2025PFIZER INC. Stock Hits Forecast Price Target with 6.27% Profit: A Success Story for QuantWave  ~2 min.

In a recent market development, PFIZER INC. stock has successfully reached the price target forecasted by QuantWave, resulting in a profit of 6.27%....


PFEJuly 10, 2025PFIZER INC. Hits Price Target with 6.35% Profit: A Success Story for QuantWave Forecasting  ~1 min.

PFIZER INC. has recently hit the price target forecasted by QuantWave, achieving a profit of 6.35% for investors. The forecast signal was generated on June 26, 2025, with a price of 23.83 $....


PFEJuly 10, 2025PFIZER INC. Hits Price Target Forecast with 6.09% Profit: QuantWave Analysis  ~1 min.

On June 10, 2025, QuantWave, the automated forecasting platform, issued a long signal for PFIZER INC. (PFE) when the stock was trading at $23.89. Fast forward to July 10, 2025, and the price target of $25....


PFEJuly 10, 2025PFIZER INC. Stock Hits Price Target Forecast with 6.05% Profit  ~1 min.

On June 24, 2025, QuantWave issued a long signal for PFIZER INC. stock when it was trading at $23.9. Analysts predicted a target price of $25....


PFENovember 11, 2024Pfizer Inc. Announces Groundbreaking Breakthrough in COVID-19 Treatment  ~2 min.

Pfizer Inc., the renowned pharmaceutical company, has made a groundbreaking discovery in the fight against COVID-19....


ABBVDecember 2, 2024AbbVie Inc. ABBV: A Promising Pharmaceutical Stock with Underrated Potential  ~2 min.

AbbVie Inc. (ABBV), a renowned pharmaceutical company, has been gaining attention as one of the most undervalued pot stocks in the market....


REGNJanuary 1, 2025Regeneron Pharmaceuticals, Inc.: Groundbreaking Discoveries in Drug Development  ~2 min.

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) has made remarkable progress in the field of drug development, delighting its investors with a decent 89% return over the past five years....


LLYMarch 17, 2025Eli Lilly and Company's Groundbreaking Discovery Revolutionizes Pharma Industry  ~2 min.

Eli Lilly and Company, a renowned pharmaceutical giant, has recently made a groundbreaking discovery that is set to revolutionize the entire industry....


FMCJanuary 12, 2025FMC Corporation Announces Breakthrough in Frontier Medicines with FMC-220  ~2 min.

FMC Corporation, a leading global chemical company, has recently announced a significant milestone in its frontier medicines division....